The EPSRC funding for the IRC, £10m over six years, enables a longer-term, interdisciplinary research programme which comprises 18 principal investigators working across five founding universities, Cambridge, Imperial, UCL, Glasgow, Birmingham and, more recently, Nottingham, Leeds, Liverpool and Strathclyde. Our shared aim is to develop and validate drug-delivery technologies to support the work of clinicians and improve survival rates for patients.
Director
Professor George Malliaras
Director of the IRC and Prince Philip Professor of Technology,
University of Cambridge
InvestigatorsProfessor Cameron Alexander Dr Ronan Daly Dr David Fairen-Jimenez Professor Ross Forgan Dr Ljiljana Fruk Professor Simon Gaisford Professor Rylie Green Dr Su Metcalfe Dr Ruman Rahman Professor Oren Scherman Dr Yan Yan Shery Huang Professor Judy Coulson Dr Clare Hoskins Ryan Mathew Associate Professor (Clinical) University of Leeds |
Clinical LeadsProfessor Richard Gilbertson Professor Duncan Jodrell Professor Stefan Marciniak Professor Colin Watts Postdoctoral ResearchersDr Ishtiaq Ahmed, Department of Chemical Engineering and Biotechnology, University of Cambridge Dr Sarah Barnett, Institute of Systems, Molecular and Integrative Biology, University of Liverpool Dr Arvin Eskandari, School of Chemistry, University of Glasgow Dr Aaron Lee, Department of Bioengineering, Imperial College London Dr Bingyuan Lu, School of Pharmacy, UCL Dr Sergio Mercado Argandona, Department of Chemical Engineering and Biotechnology, University of Cambridge Dr Gary Shaw, School of Medicine, University of Leeds Dr Amrita Sikder, Department of Chemistry, University of Cambridge Dr Jose Antonio Valer, Cambridge Institute for Medical Research, University of Cambridge Dr Xudong Tao, Department of Engineering, University of Cambridge
Core TeamClaire McGlynn Kirsty Shepherd |
